To Evaluate Safety and Immunogenicity of a Prophylactic Plasmid DNA
Clinical trial NCT06436911 · COMPLETED
Trial details
- NCT number
- NCT06436911
- Sponsor
- Entos Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-22
- Primary completion
- 2025-10-03
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.